Literature DB >> 18180157

Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains.

Anand Mayasundari1, Antonio M Ferreira, Liwen He, Neeraj Mahindroo, Don Bashford, Naoaki Fujii.   

Abstract

This report describes the first small-molecule antagonists that specifically target the ligand-binding pocket of PDZ domains of NHERF1 multi-functional adaptor protein. Comparison of the peptide sequence homology between the native ligand of NHERF1 PDZ domains and an indole-based non-peptide chemical scaffold allowed the design of a small-molecule antagonist of NHERF1 PDZ domains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18180157     DOI: 10.1016/j.bmcl.2007.12.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2.

Authors:  Stefanie L Ritter; Matthew J Asay; Maryse Paquet; Kevin J Paavola; Rachel E Reiff; C Chris Yun; Randy A Hall
Journal:  Neurosci Lett       Date:  2010-04-27       Impact factor: 3.046

2.  Structural basis for NHERF1 PDZ domain binding.

Authors:  Tatyana Mamonova; Maria Kurnikova; Peter A Friedman
Journal:  Biochemistry       Date:  2012-03-27       Impact factor: 3.162

3.  Engineering peptide inhibitors to overcome PDZ binding promiscuity.

Authors:  Lars Vouilleme; Patrick R Cushing; Rudolf Volkmer; Dean R Madden; Prisca Boisguerin
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-17       Impact factor: 15.336

4.  Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.

Authors:  Maha M Hammad; Yi-Qun Kuang; Ronald Yan; Heather Allen; Denis J Dupré
Journal:  J Biol Chem       Date:  2010-08-26       Impact factor: 5.157

5.  Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1.

Authors:  Anders Bach; Nicolai Stuhr-Hansen; Thor S Thorsen; Nicolai Bork; Irina S Moreira; Karla Frydenvang; Shahrokh Padrah; S Brøgger Christensen; Kenneth L Madsen; Harel Weinstein; Ulrik Gether; Kristian Strømgaard
Journal:  Org Biomol Chem       Date:  2010-07-29       Impact factor: 3.876

6.  Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD.

Authors:  Thor S Thorsen; Kenneth L Madsen; Nelson Rebola; Mette Rathje; Victor Anggono; Anders Bach; Irina S Moreira; Nicolai Stuhr-Hansen; Tino Dyhring; Dan Peters; Thijs Beuming; Richard Huganir; Harel Weinstein; Christophe Mulle; Kristian Strømgaard; Lars Christian B Rønn; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology.

Authors:  Venita Gresham Watson; Katherine M Drake; Yu Peng; Andrew D Napper
Journal:  Assay Drug Dev Technol       Date:  2013-05       Impact factor: 1.738

8.  NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.

Authors:  Rosa Angela Cardone; Maria Raffaella Greco; Mattia Capulli; Edward J Weinman; Giovanni Busco; Antonia Bellizzi; Valeria Casavola; Ester Antelmi; Barbara Ambruosi; Maria Elena Dell'Aquila; Angelo Paradiso; Anna Teti; Nadia Rucci; Stephan Joel Reshkin
Journal:  Mol Biol Cell       Date:  2012-04-11       Impact factor: 4.138

9.  An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.

Authors:  Garima Tiwari; Debasisa Mohanty
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

10.  Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.

Authors:  Jeremy M Fitzpatrick; Maria Pellegrini; Patrick R Cushing; Dale F Mierke
Journal:  Biochemistry       Date:  2014-09-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.